We hypothesized that in ADHD children, the efficacy of MPH and the changes in near-infrared brain function before and after MPH treatments might be related to SNAP-25 gene MnlI polymorphism. This evidence concerns the gene SNAP25 and attention deficit-hyperactivity disorder.